[An evaluation of the efficacy of the new Ukrainian preparation Erbisol in patients with chronic hepatitis].
A new drug preparation "Erbisol" was studied for its effect in the treatment of chronic hepatitis. There were 52 patients; of these, chronic active hepatitis was diagnosed in ten, persistent hepatitis in 38, cholangiolytic hepatitis in 4 patients. The preparation has a beneficial effect on the clinical course of the disease and makes for the normalization of biochemical and immunological indicators in patients with persistent hepatitis and in those with chronic active hepatitis with mild degree of activity. In patients with cholangiolytic hepatitis "Erbisol" should be used with caution. The studies made allowed for the conclusion to be drawn to the effect that the preparation "Erbisol" is a highly effective hepatoprotective and immunomodulating drug.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D001685:Biological Factors / Q000627:therapeutic use*; D002417:Cattle; D002779:Cholestasis / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000503:physiopathology; D002908:Chronic Disease; D004622:Embryo, Mammalian; D006505:Hepatitis / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology / Q000503:physiopathology; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000276:immunology / Q000503:physiopathology; D008970:Molecular Weight; D012074:Remission Induction
D000276:Adjuvants, Immunologic; D001685:Biological Factors; C096287:erbisol
Otsenka éffektivnosti novogo otechestvennogo preparata "Erbisol" u bol'nykh khronicheskim gepatitom.